中美两国药品分类管理制度比较及启示  

Comparison of American and Our Drug Classification Management System and Enlightenment

作　　者：郭莹[1] 王敬博[1] 张婉莹[1] 

机构地区：[1]沈阳药科大学工商管理学院,沈阳110016

出　　处：《中国药事》2010年第6期612-614,共3页Chinese Pharmaceutical Affairs

摘　　要：目的探讨中美两国药品分类管理制度的区别以及如何完善我国药品分类管理制度。方法采用文献查阅法对中美两国的药品分类管理制度进行比较研究。结果与结论 我国应从健全药品分类管理的法律体系,加快医疗体制改革,完善药品标签、说明书管理等方面入手来改善药品分类管理的现状。Objective This article discussed mainly how to perfect our drug classification management system based on the comparison of American and our drug classification management.Methods This article applied mainly the literature method and used American drug classification management for reference.Results and Conclusion In this paper,it supplies some suggestions such as perfecting our drug classification law system,accelerating our medical treatment system reform,perfecting our drug labels and explaining script.

关 键 词：药品分类管理 处方药 非处方药 

分 类 号：R951.2[医药卫生—药学]